Significant Ownership of Tim Kutzkey
- Location
- San Francisco, CA
- 13D/G summary
- Recent SEC Schedule 13D/G beneficial ownership filings for Tim Kutzkey.
Follow Filing Activity
Follow Tim Kutzkey and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Tim Kutzkey
Significant Ownership of Tim Kutzkey
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SRZN | Surrozen, Inc. | Common Stock, $0.0001 par value per share | 29% | $120,704,755 | 3,824,612 | 0% | Tim Kutzkey | 31 Mar 2026 | |
| SRZN | Eikon Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 12% | $131,204,153 | 6,353,712 | Tim Kutzkey | 06 Feb 2026 |
Schedules 13D/G Reported by Tim Kutzkey:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
An asterisk next to the price means the reported price is likely invalid.